- SEK354.38m
- SEK313.62m
- SEK279.09m
Brief: Mentice Announces Resignation Of CFO
Brief: Mentice Gets Order Of USD 2.4 Mln
Brief: Mentice Gets Order Of USD 0.6 Mln For Simulation Solutions
Brief: Mentice Receives Order Of $0.7 Mln From Global Medtech Company
Brief: Mentice Q1 EBITDA at SEK 7.3 Million
Brief: Mentice Gets Order Of USD 0.7 Mln For Simulation Solutions From Medtronic
Brief: Mentice Receives Order From Medtronic
Brief: Mentice Q4 Order Intake Increases TO SEK 90.3 Mln
Brief: Mentice Receives Order Worth $540,000
Brief: Mentice Receives Order Of $1.1 Mln
Brief: Mentice Q3 EBITDA Loss Widens To SEK 1.9 Mln
Brief: Mentice And Acandis Announce 3-Year Agreement
Brief: Mentice Q2 EBITDA Swings To Loss SEK 12.2 Mln
Brief: Mentice Gets Initial Order Of USD 1.93 Mln From Medtronic
Brief: Mentice Directed New Share Issue Of About SEK 60 Million Oversubscribed
Brief: Mentice AB Entered Into An Agreement With Galgo To Acquire All Assets Related To Ankyras For Total Purchase Price Of About EUR 2.775 Million
Brief: Mentice Says Intention To Carry Out Directed New Issue Of Shares Of About Sek 60 Mln Directed To Swedish And International Institutional Investors
Brief: Mentice AB Says Intention To Acquire All Assets Of Ankyras Software Suite From Galgo Medical For EUR 1.80 Mln
Brief: Mentice Q1 EBITDA Loss Narrows To SEK 1.3 Mln